BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32010312)

  • 1. Interleukin-22 modulates cisplatin sensitivity of osteosarcoma cells by regulating the STAT3 signaling pathway.
    Li Z; Xu R; Zhang X; Shen J; Chen G; Zou T; Yu X
    Exp Ther Med; 2020 Feb; 19(2):1379-1387. PubMed ID: 32010312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The induction of ferroptosis by impairing STAT3/Nrf2/GPx4 signaling enhances the sensitivity of osteosarcoma cells to cisplatin.
    Liu Q; Wang K
    Cell Biol Int; 2019 Nov; 43(11):1245-1256. PubMed ID: 30811078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [p14ARF enhances cisplatin-induced apoptosis in human osteosarcoma cells in p53-independent pathway].
    Huang X; Yuan X; Chen Z; Liang S
    Zhonghua Yi Xue Za Zhi; 2015 Sep; 95(35):2875-9. PubMed ID: 26815194
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Pei Y; Zhang Y; Zheng K; Shang G; Wang Y; Wang W; Qiu E; Li S; Liu F; Zhang X
    Onco Targets Ther; 2019; 12():4499-4507. PubMed ID: 31239718
    [No Abstract]   [Full Text] [Related]  

  • 5. Expression of Beclin1 in osteosarcoma and the effects of down-regulation of autophagy on the chemotherapeutic sensitivity.
    Zhang Z; Shao Z; Xiong L; Che B; Deng C; Xu W
    J Huazhong Univ Sci Technolog Med Sci; 2009 Dec; 29(6):737-40. PubMed ID: 20037818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of beclin1 affects the chemotherapeutic sensitivity of osteosarcoma.
    Wu W; Li W; Zhou Y; Zhang C
    Int J Clin Exp Pathol; 2014; 7(10):7114-22. PubMed ID: 25400807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of PI3K-mediated autophagy in human osteosarcoma MG63 cells on sensitivity to chemotherapy with cisplatin.
    Miao XD; Cao L; Zhang Q; Hu XY; Zhang Y
    Asian Pac J Trop Med; 2015 Sep; 8(9):731-8. PubMed ID: 26433659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of TRAF6 on proliferation, apoptosis and invasion in osteosarcoma are regulated by miR-124.
    Meng Q; Zhang W; Xu X; Li J; Mu H; Liu X; Qin L; Zhu X; Zheng M
    Int J Mol Med; 2018 May; 41(5):2968-2976. PubMed ID: 29436576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-126 enhances the sensitivity of osteosarcoma cells to cisplatin and methotrexate.
    Jiang L; He A; He X; Tao C
    Oncol Lett; 2015 Dec; 10(6):3769-3778. PubMed ID: 26788206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-133b induces chemoresistance of osteosarcoma cells to cisplatin treatment by promoting cell death, migration and invasion.
    Zou Y; Yang J; Wu J; Luo C; Huang Y
    Oncol Lett; 2018 Jan; 15(1):1097-1102. PubMed ID: 29399170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA NNT-AS1 is a major mediator of cisplatin chemoresistance in non-small cell lung cancer through MAPK/Slug pathway.
    Cai Y; Dong ZY; Wang JY
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4879-4887. PubMed ID: 30070323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-6 Promotes Cancer Stemness and Oncogenicity in U2OS and MG-63 Osteosarcoma Cells by Upregulating the OPN-STAT3 Pathway.
    Zhang C; Ma K; Li WY
    J Cancer; 2019; 10(26):6511-6525. PubMed ID: 31777581
    [No Abstract]   [Full Text] [Related]  

  • 13. [Molecular mechanism of cisplatin to enhance the ability of TRAIL in reversing multidrug resistance in gastric cancer cells].
    Zhu X; Zhang K; Wang Q; Chen S; Gou Y; Cui Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):404-11. PubMed ID: 26463141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcl-2 small interfering RNA sensitizes cisplatin-resistant human lung adenocarcinoma A549/DDP cell to cisplatin and diallyl disulfide.
    Huang Z; Lei X; Zhong M; Zhu B; Tang S; Liao D
    Acta Biochim Biophys Sin (Shanghai); 2007 Nov; 39(11):835-43. PubMed ID: 17989874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RKIP promotes cisplatin-induced gastric cancer cell death through NF-κB/Snail pathway.
    Liu H; Li P; Li B; Sun P; Zhang J; Wang B; Jia B
    Tumour Biol; 2015 Mar; 36(3):1445-53. PubMed ID: 25547433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.
    Shi H; Pu J; Zhou XL; Ning YY; Bai C
    Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interference with HMGB1 increases the sensitivity to chemotherapy drugs by inhibiting HMGB1-mediated cell autophagy and inducing cell apoptosis.
    Zhang R; Li Y; Wang Z; Chen L; Dong X; Nie X
    Tumour Biol; 2015 Nov; 36(11):8585-92. PubMed ID: 26040768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biological effect of down-regulating of MTRR gene on cisplatin-resistant ovarian cancer SKOV3 cells in vitro and in vivo studies].
    Chen J; Wang Q; Zhang W; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2016 Feb; 51(2):126-34. PubMed ID: 26917482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bcl-XL small interfering RNA sensitizes cisplatin-resistant human lung adenocarcinoma cells.
    Lei X; Huang Z; Zhong M; Zhu B; Tang S; Liao D
    Acta Biochim Biophys Sin (Shanghai); 2007 May; 39(5):344-50. PubMed ID: 17492131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TIMP3 Overexpression Improves the Sensitivity of Osteosarcoma to Cisplatin by Reducing IL-6 Production.
    Han XG; Mo HM; Liu XQ; Li Y; Du L; Qiao H; Fan QM; Zhao J; Zhang SH; Tang TT
    Front Genet; 2018; 9():135. PubMed ID: 29731768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.